In conclusion, this study identified hub genes and crucial biological pathways related to ESCC tumorigenesis and integrated analyses indicated that CDC6 may be a novel diagnostic and therapeutic target for ESCC. The gene discussed is CDC6; the disease is esophageal squamous cell carcinoma.